Defibrotide, a profibrinolytic drug, reduces damage due to post-ischaemic reperfusion in rats.
Ferrero
M E
ME
Istituto di Patologia Generale and Centro di Studio sulla Patologia Cellulare del CNF, Milan, Italy.
Marni
A
A
Gaja
G
G
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D007511:Ischemia / Q000150:complications*; D007668:Kidney / Q000098:blood supply*; D008099:Liver / Q000098:blood supply*; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D015427:Reperfusion Injury / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide; D000255:Adenosine Triphosphate